racing medication and testing consortium

Radosevich Returning From 15-Day Levamisole Suspension In Ohio

Jeffrey Radosevich, perennially the leading trainer at Mahoning Valley Race Course in Youngstown, Ohio, is set to return from a 15-day suspension for a medication violation in December. Radosevich was fined $500 and suspended by the board of stewards from Feb. 9 through Feb. 23 after Ron Paolucci Racing’s Dinesen, winner of the sixth race […]

Continue reading
View From The Eighth Pole: It’s Time To Get Rid Of Clenbuterol

It’s been nearly eight years since the late Kent Stirling, then the executive director of the Florida Horsemen’s Benevolent and Protective Association, said during a Congressional hearing on “Medication and Performance-Enhancing Drugs in Horse Racing” that the bronchodilator clenbuterol is “probably the best drug that’s come out in 30 years.” Veterinarians I’ve spoken to have […]

Continue reading
Disqualified: Silver Dust Tested Positive For Levamisole After Louisiana Stakes

Silver Dust, winner of yesterday’s Grade 3 Mineshaft Stakes at the Fair Grounds, has been disqualified from his Jan. 18 win in the G3 Louisiana Stakes after testing positive for levamisole, reports the Daily Racing Form. Trainer Bret Calhoun agreed to a $1,000 fine and the disqualification, placing Silver Dust last. The Racing Medication and Testing […]

Continue reading
Joe Sharp Has Eight Horses Disqualified At Fair Grounds; Additional Cases Pending In Kentucky

Trainer Joe Sharp, who had eight horses disqualified at Fair Grounds in Louisiana because of positive tests for the Class 2 drug levamisole, said similar cases are pending from multiple horses from his barn who competed at the Churchill Downs fall meet in Kentucky. Daily Racing Form first reported that Sharp was fined $1,000 by […]

Continue reading
Chrome, Zenyatta, Tapit And More: RMTC To Auction Popular Horse Halters For Tactical Research Program

Beginning at 1 p.m. ET on December 2 and running for one week, the Racing Medication and Testing Consortium (RMTC), an industry 501(c)(3) nonprofit organization, will auction off halters of history-making racehorses, stallions and broodmares on its eBay page. All proceeds from this auction go to the RMTC’s Tactical Research Program, which funds studies focused on the […]

Continue reading
RMTC Approves New Restrictions On Non-Steroidal Anti-Inflammatories

During a November 15 meeting by phone, the Racing Medication and Testing Consortium (RMTC) board approved further regulations and stacking prohibitions, as well as corresponding threshold and penalty recommendations, for non-steroidal anti-inflammatory drugs (NSAIDs) and intra-articular (IA) injections.  The RMTC board has recommend a 48-hour Restricted Administration Time policy for all NSAIDs. Currently, the administration of one […]

Continue reading
CHRB: No Prohibited Substances Found In Breeders’ Cup Drug Tests

All samples collected from 2019 Breeders’ Cup horses have been cleared by the Kenneth L. Maddy Equine Analytical Chemistry Laboratory at the University of California, Davis, the California Horse Racing Board announced on the evening of Nov. 6. All horses competing in Breeders’ Cup races Nov. 1 and Nov. 2 at Santa Anita Park underwent […]

Continue reading
Ohio Racing Commission Adopts Therapeutic Medication Thresholds

The Ohio State Racing Commission adopted therapeutic medication thresholds at its September 23 meeting. The thresholds become effective January 1, 2020. The resolution was presented by Commissioner Beth Hansen, chairperson of the Commission’s Medication Committee. The Medication Committee met on three previous occasions to review and discuss existing Commission therapeutic medication thresholds, the Racing Medication […]

Continue reading
RMTC Approves Model Rules For Bisphosphonates Regulation

At its August 19 meeting at Del Mar Turf Club in Del Mar, California, the Racing Medication and Testing Consortium (RMTC) board approved a model rule for the regulation of bisphosphonates as well as further regulations and stacking prohibitions for non-steroidal anti-inflammatory drugs (NSAIDs) and intra-articular (IA) injections. The proposed Model Rule for the regulation […]

Continue reading
Twitter Twitter
Paulick Report on Instagram